Predicting the advent of ascites and other complications in primary biliary cirrhosis: a staged model approachCHAN, C.-W; TSOCHATZIS, E. A; CARPENTER, J. R et al.Alimentary pharmacology & therapeutics. 2010, Vol 31, Num 5, pp 573-582, issn 0269-2813, 10 p.Article

Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohortPAPASTERGIOU, V; TSOCHATZIS, E. A; THORBURN, D et al.Alimentary pharmacology & therapeutics. 2014, Vol 39, Num 7, pp 721-732, issn 0269-2813, 12 p.Article

Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort studyPAPASTERGIOU, V; TSOCHATZIS, E. A; BURROUGHS, A. K et al.Alimentary pharmacology & therapeutics. 2013, Vol 38, Num 11-12, pp 1354-1364, issn 0269-2813, 11 p.Article

Elastography for the diagnosis of severity of fibrosis in chronic liver disease: A meta-analysis of diagnostic accuracyTSOCHATZIS, E. A; GURUSAMY, K. S; NTAOULA, S et al.Journal of hepatology. 2011, Vol 54, Num 4, pp 650-659, issn 0168-8278, 10 p.Article